While no one can answer this question with absolute certainty, recent studies indicate that CBD might have no negative side effects at all. Until research proves otherwise, the legal status of Cannabidiol is safe and will remain unchanged for the foreseeable future. Therefore, it seems that you can safely consume CBD without worry as long as it contains only traces amounts of THC (like CBD Supplements made from hemp not marijuana).

There’s a growing consensus that cannabis is a highly effective treatment for many kinds of neuropathic pain. A 2015 study published in Neurotherapeutics states, “Clinical studies largely affirm that neuropathic pain patients derive benefits from cannabinoid treatment.”   But much of the human-based research (like this study) on CBD and nerve pain has centered around the efficacy of the FDA-approved medication Sativex, which includes both THC and CBD. Research on the best CBD for pain isolated from THC is still limited when it comes to neuropathic pain. There are exceptions, though:
CBD oil sourced from hemp is legal all across the U.S when sold as a dietary supplement. Our full-spectrum CBD oil products, when taken daily, add CBD, as well as essential vitamins, minerals, fatty acids, terpenes, flavonoids, and other trace cannabinoids, to your healthy diet. Try one of these healthy recipes for easily adding CBD into your meals.
CBDPure has both strengths and weaknesses. We’ve seen worse, and we’ve seen better supplements. To minimize investment risks, we advise that you test the customer service first, by sending them an email, and only place the order after you’ve made sure they are responsive. They have an online chat option. However, considering that the website and the terms and conditions ask that you send emails, it is safer to stick to their recommendations.
And we have a long way to go before we fully understand the relationship between CBD and pain regulation. But strong anecdotal evidence, combined with multiple lab tests and even some clinical trials, have established that CBD holds a lot of promise for pain relief. Or in science-speak, CBD “represents a novel class of therapeutic agents for the treatment of chronic pain.”
The passing of SB 218 through the Kentucky legislature created a new subsection of KRS 260.850m to 260.289, in which the Industrial Hemp Advisory Board outlines the purpose of an industrial hemp research program, establish license provisions, and create new requirements and license application procedures. This state’s approach is for the potential medical and industrial applications.
×